EntrarCadastrar

/

Anagrelide

Visão geral

Anagrelide is a drug used for the treatment of essential thrombocytosis, or overproduction of blood platelets. It also has been used in the treatment of chronic myeloid leukemia. Anagrelide controlled release is in phase III clinical trials by Galena Biopharma for the treatment of essential thrombocytosis

A Anant Labs fabrica e fornece impurezas de Anagrelide de alta qualidade para o mercado global. Nossas impurezas EP de Anagrelide são utilizadas por fabricantes de APIs e empresas farmacêuticas totalmente integradas em todo o mundo.

Ingrediente Farmacêutico Ativo

Chemical structure of Anagrelide

Anagrelide

Mol. Formula: C₁₀H₇Cl₂N₃O
Mol. Weight: 256.092

Impurezas (4)

Chemical structure of Anagrelide Ethyl ester

Anagrelide Ethyl ester

Cat. No.: ANT-ANG-02
CAS: 70381-75-8
Mol. Formula: C₁₂H₁₄BrCl₂N₃O₂
Mol. Weight: 302.16

Chemical structure of Anagrelide Methyl ester

Anagrelide Methyl ester

Cat. No.: ANT-ANG-01
CAS: 752151-24-9
Mol. Formula: C₁₁H₁₁Cl₂N₃O₂
Mol. Weight: 288.13

Chemical structure of Anagrelide USP Related Compound A

Anagrelide USP Related Compound A

Cat. No.: ANT-ANG-003
CAS: 70406-92-7
Mol. Formula: C₁₁H₁₄Cl₂N₂O₂
Mol. Weight: 277.15

Chemical structure of Anagrelide USP Related Compound B (HBr salt)

Anagrelide USP Related Compound B (HBr salt)

Cat. No.: ANT-ANG-004
CAS: 1194434-39-3
Mol. Formula: C₁₀H₉Cl₂N₃O₂.HBr
Mol. Weight: 355.02